Subrata Deb

1.4k total citations
53 papers, 1.0k citations indexed

About

Subrata Deb is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Subrata Deb has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Pharmacology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Subrata Deb's work include Pharmacogenetics and Drug Metabolism (11 papers), Ginseng Biological Effects and Applications (8 papers) and COVID-19 Clinical Research Studies (8 papers). Subrata Deb is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Ginseng Biological Effects and Applications (8 papers) and COVID-19 Clinical Research Studies (8 papers). Subrata Deb collaborates with scholars based in United States, Canada and India. Subrata Deb's co-authors include Debasish Basak, Emma S. Tomlinson Guns, Mohamed Ben‐Eltriki, Hans Adomat, Stelvio M. Bandiera, Baskar Mannargudi, Lawrence Rothfield, B Glauner, T J MacAlister and Prashant Sakharkar and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Subrata Deb

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Subrata Deb United States	18	431	152	150	149	137	53	1.0k
Hitoshi Ishizuka Japan	17	468 1.1×	235 1.5×	197 1.3×	141 0.9×	114 0.8×	56	1.4k
Erika Roat Italy	19	754 1.7×	70 0.5×	63 0.4×	82 0.6×	89 0.6×	26	1.6k
Peiyong Zheng China	21	486 1.1×	124 0.8×	37 0.2×	88 0.6×	93 0.7×	81	1.2k
Shih‐Lu Wu Taiwan	24	610 1.4×	395 2.6×	60 0.4×	89 0.6×	61 0.4×	39	1.5k
Shijun He China	24	687 1.6×	186 1.2×	131 0.9×	53 0.4×	94 0.7×	82	1.7k
Jianghong Fan United States	20	423 1.0×	307 2.0×	49 0.3×	109 0.7×	92 0.7×	45	1.5k
Tomoko Yoshinari Japan	19	624 1.4×	50 0.3×	112 0.7×	238 1.6×	130 0.9×	33	1.2k
Chi Chun Wong United Kingdom	16	599 1.4×	83 0.5×	272 1.8×	67 0.4×	134 1.0×	29	1.3k
Steven J. Melnick United States	20	626 1.5×	129 0.8×	100 0.7×	132 0.9×	20 0.1×	52	1.6k

Countries citing papers authored by Subrata Deb

Since Specialization

Citations

This map shows the geographic impact of Subrata Deb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subrata Deb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subrata Deb more than expected).

Fields of papers citing papers by Subrata Deb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subrata Deb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subrata Deb. The network helps show where Subrata Deb may publish in the future.

Co-authorship network of co-authors of Subrata Deb

This figure shows the co-authorship network connecting the top 25 collaborators of Subrata Deb. A scholar is included among the top collaborators of Subrata Deb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subrata Deb. Subrata Deb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deb, Subrata, et al.. (2025). Artificial Intelligence in Urology—A Survey of Urology Healthcare Providers. SHILAP Revista de lepidopterología. 6(4). 53–53.

Ben‐Eltriki, Mohamed, et al.. (2024). Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes. Life. 14(4). 510–510. 2 indexed citations

Deb, Subrata & Prashant Sakharkar. (2024). Comparison of NAPLEX First-Time Pass Rates Before and After COVID-19 Pandemic. American Journal of Pharmaceutical Education. 88(9). 100916–100916.

Deb, Subrata, et al.. (2024). ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels. SHILAP Revista de lepidopterología. 11(3). 6–6. 3 indexed citations

Sakharkar, Prashant, et al.. (2024). Investigating the Efficacy of EGFR-TKIs and Anti-VEGFR Combination in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis. Cancers. 16(6). 1188–1188. 4 indexed citations

Deb, Subrata, et al.. (2024). Significance of Chalcone Scaffolds in Medicinal Chemistry. Topics in Current Chemistry. 382(3). 22–22. 15 indexed citations

Ben‐Eltriki, Mohamed, et al.. (2023). Pharmacological Significance of Heme Oxygenase 1 in Prostate Cancer. Current Issues in Molecular Biology. 45(5). 4301–4316. 10 indexed citations

Deb, Subrata, Mohamed Ben‐Eltriki, Hans Adomat, Mei Yieng Chin, & Emma S. Tomlinson Guns. (2023). Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis. SHILAP Revista de lepidopterología. 10(3). 21–21. 1 indexed citations

Deb, Subrata, et al.. (2022). Evaluation of pharmacogenomic evidence for drugs related to ADME genes in CPIC database. Drug Metabolism and Personalized Therapy. 38(1). 65–78. 1 indexed citations

10.

Ben‐Eltriki, Mohamed, et al.. (2022). Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies. Journal of Pharmacy & Pharmaceutical Sciences. 25. 124–136. 17 indexed citations

11.

Ben‐Eltriki, Mohamed, Subrata Deb, Takeshi Yamazaki, et al.. (2021). Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer. SHILAP Revista de lepidopterología. 8(6). 28–28. 7 indexed citations

12.

Deb, Subrata, et al.. (2021). Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions. Journal of Pharmacy & Pharmaceutical Sciences. 24. 277–291. 24 indexed citations

13.

Ben‐Eltriki, Mohamed, Subrata Deb, & Emma S. Tomlinson Guns. (2021). 1α,25-Dihydroxyvitamin D3 synergistically enhances anticancer effects of ginsenoside Rh2 in human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 209. 105828–105828. 13 indexed citations

14.

Deb, Subrata, et al.. (2020). Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis. Journal of Pharmacy & Pharmaceutical Sciences. 23. 396–405. 22 indexed citations

15.

Benavides, Sandra, et al.. (2019). Comparison of NAPLEX pass rates for non-modifiable determinants of pharmacy programs in the United States. Currents in Pharmacy Teaching and Learning. 11(11). 1117–1122. 12 indexed citations

16.

Ben‐Eltriki, Mohamed, Subrata Deb, & Emma S. Tomlinson Guns. (2016). Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions. Journal of Cancer. 7(4). 391–407. 31 indexed citations

17.

Deb, Subrata, Mei Yieng Chin, Hans Adomat, & Emma S. Tomlinson Guns. (2013). Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro. The Journal of Steroid Biochemistry and Molecular Biology. 144. 50–58. 16 indexed citations

18.

Deb, Subrata, Masahiko Kawai, Thomas K. H. Chang, & Stelvio M. Bandiera. (2010). CYP1B1 expression in rat testis and Leydig cells is not inducible by aryl hydrocarbon receptor agonists. Xenobiotica. 40(7). 447–457. 10 indexed citations

19.

Deb, Subrata & Stelvio M. Bandiera. (2009). Characterization and expression of extrahepatic CYP2S1. Expert Opinion on Drug Metabolism & Toxicology. 5(4). 367–380. 13 indexed citations

20.

Deb, Subrata, et al.. (2008). Synthesis and evaluation of L-glutamic acid analogs as potential anticancer agents. Indian Journal of Pharmaceutical Sciences. 70(2). 245–245. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact